{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:41:51Z","timestamp":1759549311571,"version":"build-2065373602"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.2169\/internalmedicine.5029-24","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:14:52Z","timestamp":1741976092000},"page":"2846-2851","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Biologics against Interleukin-5 Administered to Patients with Eosinophilic Gastroenteritis"],"prefix":"10.2169","volume":"64","author":[{"given":"Kazuya","family":"Miyaguchi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Hepatology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Imaeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kinoshita Y, Yahata S, Oouchi S. Eosinophilic gastrointestinal diseases: the pathogenesis, diagnosis, and treatment. Intern Med 62: 1-10, 2023.","DOI":"10.2169\/internalmedicine.8417-21"},{"key":"2","unstructured":"2. Dellon ES, Gonsalves N, Abonia JP, et al. International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. Clin Gastroenterol Hepatol 20: 2474-2484, 2022."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamamoto MJ, Nagashima S, Yamada Y, et al. Comparison of nonesophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: a nationwide survey. J Allergy Clin Immunol Pract 9: 3339-3349.e8, 2021.","DOI":"10.1016\/j.jaip.2021.06.026"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Khan S. Eosinophilic gastroenteritis. Best Pract Res Clin Gastroenterol 19: 177-198, 2005.","DOI":"10.1016\/j.bpg.2005.01.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bischoff SC, Ulmer FA. Eosinophils and allergic diseases of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 22: 455-479, 2008.","DOI":"10.1016\/j.bpg.2007.11.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bischoff SC. Food allergy and eosinophilic gastroenteritis and colitis. Curr Opin Allergy Clin Immunol 10: 238-245, 2010.","DOI":"10.1097\/ACI.0b013e32833982c3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 31: 185-205, 2009.","DOI":"10.1007\/s00281-009-0165-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ashitani K, Tsuzuki Y, Yamaoka M, et al. Endoscopic features and diagnostic procedures of eosinophilic gastroenteritis. Intern Med 58: 2167-2171, 2019.","DOI":"10.2169\/internalmedicine.2298-18"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arakawa H, Adachi Y, Ebisawa M, Fujisawa T. Japanese guidelines for childhood asthma 2020. Allergol Int 69: 314-330, 2020.","DOI":"10.1016\/j.alit.2020.02.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P. Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab. Dig Dis Sci 64: 2231-2241, 2019.","DOI":"10.1007\/s10620-019-05617-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dellon ES, Peterson KA, Murray JA, et al. Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis. N Engl J Med 383: 1624-1634, 2020.","DOI":"10.1056\/NEJMoa2012047"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Prussin C, James SP, Huber MM, Klion AD, Metcalfe DD. Pilot study of anti-IL-5 in eosinophilic gastroenteritis. J Allergy Clin Immunol 111: S275, 2003.","DOI":"10.1016\/S0091-6749(03)80986-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kim YJ, Prussin C, Martin B, et al. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. J Allergy Clin Immunol 114: 1449-1455, 2004.","DOI":"10.1016\/j.jaci.2004.08.027"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hirata Y, Nakamura T, Higuchi K. A case of eosinophilic gastroenteritis remission achieved steroid-free with mepolizumab. Gastro Hep Adv 1: 553-554, 2022.","DOI":"10.1016\/j.gastha.2022.03.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ito K, Shibuya T, Nomura K, et al. Successful treatment of steroid-resistant eosinophilic gastrointestinal disease with mepolizumab. Intern Med 62: 3461-3467, 2023.","DOI":"10.2169\/internalmedicine.0801-22"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2144-2148, 2000.","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Caruso C, Colantuono S, Pugliese D, et al. Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report. Allergy Asthma Clin Immunol 16: 27, 2020.","DOI":"10.1186\/s13223-020-00423-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kuang FL, De Melo MS, Makiya M, et al. Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease. J Allergy Clin Immunol Pract 10: 1598-1605.e2, 2022.","DOI":"10.1016\/j.jaip.2022.02.037"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rothenberg ME, Dellon ES, Collins MH, et al. Eosinophil depletion with benralizumab for eosinophilic esophagitis. N Engl J Med 390: 2252-2263, 2024.","DOI":"10.1056\/NEJMoa2313318"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kliewer KL, Murray-Petzold C, Collins MH, et al. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol 9: 803-815, 2023.","DOI":"10.1016\/S2468-1253(23)00145-0"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Arakawa N, Yagi H, Shimizu M, et al. Dupilumab leads to clinical improvements including the acquisition of tolerance to causative foods in non-eosinophilic esophagitis eosinophilic gastrointestinal disorders. Biomolecules 13: 112, 2023.","DOI":"10.3390\/biom13010112"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_5029-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:21:26Z","timestamp":1759548086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_5029-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":21,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5029-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"5029-24"}}